Details of the Drug

General Information of Drug (ID: DMV0CXN)

Drug Name

1,1,1,3-Tetrafluoro-7-phenylheptan-2-one

Synonyms

SCHEMBL3489536; CHEMBL1096056; NWIVHHJMCFVMET-UHFFFAOYSA-N; 1,1,1,3-Tetrafluoro-7-phenyl-2-heptanone

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

262.24

Logarithm of the Partition Coefficient (xlogp)

4.7

Rotatable Bond Count (rotbonds)

6

Hydrogen Bond Donor Count (hbonddonor)

0

Hydrogen Bond Acceptor Count (hbondacc)

5

Chemical Identifiers

Formula: C13H14F4O
IUPAC Name: 1,1,1,3-tetrafluoro-7-phenylheptan-2-one
Canonical SMILES: C1=CC=C(C=C1)CCCCC(C(=O)C(F)(F)F)F
InChI: InChI=1S/C13H14F4O/c14-11(12(18)13(15,16)17)9-5-4-8-10-6-2-1-3-7-10/h1-3,6-7,11H,4-5,8-9H2
InChIKey: NWIVHHJMCFVMET-UHFFFAOYSA-N

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cytosolic phospholipase A2 (GIVA cPLA2)	TTT1JVS	PA24A_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2. J Med Chem. 2010 May 13;53(9):3602-10.